Clinical Trial Update: FinnDiane LifeOne Study - Impact of Ageing on People With Type 1 Diabetes

View source ↗

Summary

The FinnDiane LifeOne study examining aging effects in people with Type 1 diabetes is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Diabetes Mellitus Type 1, Healthy Ageing | Status: ENROLLING_BY_INVITATION